Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells
Mast cells (MCs) act as primary effectors in inflammatory and allergic reactions by releasing intracellularly-stored inflammatory mediators in diseases. The two major pathways for MC activation are known to be immunoglobulin E (IgE)-dependent and -independent. Although IgE-dependent signaling is the...
| الحاوية / القاعدة: | Cells |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
MDPI AG
2021-10-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/2073-4409/10/11/2906 |